Review of Preclinical and Clinical Studies of Bone Marrow-Derived Cell Therapies for Intracerebral Hemorrhage
Stroke is the second leading cause of mortality worldwide, causing millions of deaths annually, and is also a major cause of disability-adjusted life years. Hemorrhagic stroke accounts for approximately 10 to 27% of all cases and has a fatality rate of about 50% in the first 30 days, with limited tr...
Saved in:
| Main Authors: | Paulo Henrique Rosado-de-Castro, Felipe Gonçalves de Carvalho, Gabriel Rodriguez de Freitas, Rosalia Mendez-Otero, Pedro Moreno Pimentel-Coelho |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2016-01-01
|
| Series: | Stem Cells International |
| Online Access: | http://dx.doi.org/10.1155/2016/4617983 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bone Marrow-Derived Cells as a Therapeutic Approach to Optic Nerve Diseases
by: Louise A. Mesentier-Louro, et al.
Published: (2016-01-01) -
The Current State of Cell Therapies for Cerebrovascular Diseases
by: Jukka Jolkkonen, et al.
Published: (2016-01-01) -
Corrigendum to “Increasing Dose of Autologous Bone Marrow Mononuclear Cells Transplantation Is Related to Stroke Outcome: Results from a Pooled Analysis of Two Clinical Trials”
by: Francisco Moniche, et al.
Published: (2017-01-01) -
Intracerebral Hemorrhage
by: Tsong-Hai Lee
Published: (2024-11-01) -
Erratum to “Preconditioning of Rat Bone Marrow-Derived Mesenchymal Stromal Cells with Toll-Like Receptor Agonists”
by: Fabiana Evaristo-Mendonça, et al.
Published: (2020-01-01)